Eithan Galun

16.5k citations

206 papers · 12.6k indexed · 3 hit papers · h-index 57

Impact in

Hepatology top 0.2%
- Hepatitis C virus research
Cancer Research top 0.5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation

Papers in

Hepatology 54
- Liver physiology and pathology 17
- Hepatitis C virus research 17
- Hepatocellular Carcinoma Treatment and Prognosis 17
Immunology 44
- Immunotherapy and Immune Responses 20

Co-authors: Rinat Abramovitch Eli Pikarsky Ilan Stein Rinnat M. Porat Yinon Ben‐Neriah Sharon Amit Simcha Urieli-Shoval Amnon Peled
Journals: Molecular Therapy (13 papers)Hepatology (12 papers)PLoS ONE (11 papers)Radiology (8 papers)Oncotarget (8 papers)
Partner nations: Israel United States Germany

In The Last Decade

Eithan Galun

203 papers receiving 12.4k citations

Hit Papers

align trajectories log scale

The H19 Non-Coding RNA Is Essential for Human Tumor Growth 2007 · 555 citations

Peers

Countries citing papers authored by Eithan Galun

Since Specialization

Citations

This map shows the geographic impact of Eithan Galun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eithan Galun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eithan Galun more than expected).

Fields of papers citing papers by Eithan Galun

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eithan Galun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eithan Galun. The network helps show where Eithan Galun may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Eithan Galun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Eithan Galun Line = papers co-authored together Eithan Galun links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The oncogenic microRNA miR-222 promotes human LINE-1 retrotransposition RNA Biology ·Siew Teck Kiong, Novelasari Novelasari, Y. Schlesinger, 眞人野呂, Haizhen Sun, سیده معصومه ملکیضیابری, J.B SILVA, Eithan Galun, Daniel Goldenberg	2025	0
2	IL-6 Trans-Signaling Is Increased in Diabetes, Impacted by Glucolipotoxicity, and Associated With Liver Stiffness and Fibrosis in Fatty Liver Disease Diabetes ·晴江岡田, Harald Heuser, Laurent Bilodeau, Catherine Huët, Assia Belblidia, Cindy Baldwin, Jeanne‐Marie Giard, Laurent Biertho, Santo Unsri, Christian Couture, Angela Cheung, Bich Nguyen, Eithan Galun, Chantal Bémeur, Marc Bilodeau, Mathieu Laplante, An Tang, May Faraj, Jennifer L. Estall	2023	14
3	Multiple Roles of IL6 in Hepatic Injury, Steatosis, and Senescence Aggregate to Suppress Tumorigenesis Cancer Research ·Anat Shriki, Abhay Thoppal Shiva, Amir Sonnenblick, 永波向, Jhoset Torrenegra-Contreras, Rinat Abramovitch, Nofar Rosenberg, Orit Pappo, Sharona Elgavish, Yuval Nevo, Rifaat Safadi, Amnon Peled, Stefan Rose‐John, Eithan Galun, Jonathan H. Axelrod	2021	16
4	Single Dose of the CXCR4 Antagonist BL-8040 Induces Rapid Mobilization for the Collection of Human CD34+ Cells in Healthy Volunteers Clinical Cancer Research ·Michal Abraham, Yaron Pereg, Baruch Bulvik, Shiri Klein, Inbal Mishalian, Tara Crowley, Orly Eizenberg, Katia Beider, Arnon Nagler, Bernardo Almonacid, Rei-Fong Li, Bo Hu, Eithan Galun, Yoseph Caraco, Reuven Or, Amnon Peled	2017	41
5	CXCR4 Promotes Neuroblastoma Growth and Therapeutic Resistance through miR-15a/16-1–Mediated ERK and BCL2/Cyclin D1 Pathways Cancer Research ·Shiri Klein, Michal Abraham, Baruch Bulvik, Владимир Маркович Исаков, Ido D. Weiss, Neta Barashi, Rinat Abramovitch, Hanna Wald, Peter S Spencer, Devorah Olam, Lola Weiss, Katia Beider, Orly Eizenberg, Ori Wald, Eithan Galun, Yaron Pereg, Amnon Peled	2017	48
6	The Sphingosine-1-Phosphate Modulator FTY720 Targets Multiple Myeloma via the CXCR4/CXCL12 Pathway Clinical Cancer Research ·Katia Beider, Michel Picard, Plamen Tzokov, Avichai Shimoni, Merav Leiba, Maya Koren‐Michowitz, Elena Ribakovsky, Shiri Klein, Devorah Olam, Lola Weiss, Hanna Wald, Michal Abraham, Eithan Galun, Amnon Peled, Fulvio Grassi Marangione	2016	33
7	Radiation-Induced Loss of Salivary Gland Function Is Driven by Cellular Senescence and Prevented by IL6 Modulation Cancer Research ·Yitzhak Marmary, M.F. Colom-Reyes, N.D. Kim, G BRUCEJR, Alexander Maly, Jonathan Cohen, Ron Eliashar, Cyril André, Y. O. Kotsegub, Bruce J. Baum, Stefan Rose‐John, Eithan Galun, Jonathan H. Axelrod	2016	97
8	Irreversible Electroporation versus Radiofrequency Ablation: A Comparison of Local and Systemic Effects in a Small-Animal Model Radiology ·Baruch Bulvik, Nir Rozenblum, 恵冰潔, Muneeb Ahmed, RÍO PIEDRAS, Eithan Galun, S. Nahum Goldberg	2016	97
9	Macrophages Regulate the Systemic Response to DNA Damage by a Cell Nonautonomous Mechanism Cancer Research ·Mahdi Aldhafiri, Diane K. Mccolley, Sharona Even‐Ram, Yoav Smith, Eithan Galun, Jacob Rachmilewitz	2015	17
10	Combination of Imatinib with CXCR4 Antagonist BKT140 Overcomes the Protective Effect of Stroma and Targets CML In Vitro and In Vivo Molecular Cancer Therapeutics ·Katia Beider, Merav Darash‐Yahana, 裕介大石, Maya Koren‐Michowitz, Michal Abraham, Hanna Wald, Ori Wald, Eithan Galun, Orly Eizenberg, Amnon Peled, Arnon Nagler	2014	51
11	The High-Affinity CXCR4 Antagonist BKT140 Is Safe and Induces a Robust Mobilization of Human CD34+ Cells in Patients with Multiple Myeloma Clinical Cancer Research ·Amnon Peled, Michal Abraham, Irit Avivi, Jacob M. Rowe, Katia Beider, Hanna Wald, Ángela Natalia Ortíz Arteaga, Nathan Alexander Mehlhop, Diana Briel, A. F., Sylvie Kirsch, Eithan Galun, Luis Donizetti da Silva Stracieri, Orly Eizenberg, Izhar Hardan, Avichai Shimoni, Arnon Nagler	2013	70
12	Targeting the CD20 and CXCR4 Pathways in Non-Hodgkin Lymphoma with Rituximab and High-Affinity CXCR4 Antagonist BKT140 Clinical Cancer Research ·Katia Beider, Elena Ribakovsky, Michal Abraham, Hanna Wald, Lola Weiss, Michel Picard, Eithan Galun, Abraham Avigdor, Orly Eizenberg, Amnon Peled, Arnon Nagler	2013	48
13	Accelerated carcinogenesis following liver regeneration is associated with chronic inflammation-induced double-strand DNA breaks Proceedings of the National Academy of Sciences ·Hila Barash, Tanvir Hasan, Daniëlle Mulder, Ezra Ella, Ariel Israel, Irit Cohen, Jitka Škrottová, Tehila Ben-Moshe, Orit Pappo, Eli Pikarsky, Daniel Goldenberg, Yosef Shiloh, Eithan Galun, Rinat Abramovitch	2010	92
14	Molecular Mechanisms of Liver Carcinogenesis in the Mdr2-Knockout Mice Molecular Cancer Research ·Mark Katzenellenbogen, Lina Mizrahi, Orit Pappo, Hua Zhang, Devorah Olam, Jasmine Jacob‐Hirsch, Ninette Amariglio, Gideon Rechavi, Eytan Domany, Eithan Galun, Daniel Goldenberg	2007	81
15	Multiple Adaptive Mechanisms to Chronic Liver Disease Revealed at Early Stages of Liver Carcinogenesis in the Mdr2-Knockout Mice Cancer Research ·Mark Katzenellenbogen, Orit Pappo, Hila Barash, Hua Zhang, Lina Mizrahi, Devorah Olam, Jasmine Jacob‐Hirsch, Ninette Amariglio, Gidi Rechavi, Leslie A. Mitchell, Ron Kohen, Eytan Domany, Eithan Galun, Daniel Goldenberg	2006	74
16	IFN-γ Acts on T Cells to Induce NK Cell Mobilization and Accumulation in Target Organs The Journal of Immunology ·Ori Wald, Ido D. Weiss, Hanna Wald, Hadas Shoham, 斎藤寿彦, Katia Beider, Eithan Galun, Lola Weiss, Liat Flaishon, Idit Shachar, Arnon Nagler, Bao Lu, Craig Gérard, Ji‐Liang Gao, Eyal Mishani, Joshua Μ. Farber, Amnon Peled	2006	77
17	Small interfering RNA Inhibits Hepatitis B virus replication in mice Molecular Therapy ·Hilla Giladi, Mali Ketzinel‐Gilad, Ludmila Rivkin, Eric Hitti, Ofer Nussbaum, Eithan Galun	2003	248
18	Primary sclerosing cholangitis and liver transplantation Transplantation Proceedings ·Rifaat Safadi, Yaron Ilan, Eithan Galun, Yaffa Ashur, Eran Goldin, Orit Papo, Oded Jurim, Arye Blachar, Ahmed Eid	1999	3
19	Undetectable caeruloplasmin values in a patient with autoimmune chronic active hepatitis. Gut ·Yaron Ilan, Magnus Hillman, Ran Oren, Eithan Galun, Meir Shalit	1991	8
20	9163 家相の文献に見る樹木と方位-2 PubMed Central ·Eithan Galun, Yaron Ilan, N Livni, Hai Lang, Ika Fitria, Galina Pizov, Arnon Nagler, Wanlaya Tipkantha, Avraham Rivkind, Godrylh Gálvez	1990	41

About Eithan Galun

Eithan Galun is a scholar working on Hepatology, Immunology, Cancer Research, Oncology and Epidemiology, having authored 206 papers that have together received 12.6k indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (26 papers), Liver Disease Diagnosis and Treatment (23 papers), Virus-based gene therapy research (20 papers), Immunotherapy and Immune Responses (20 papers), Chemokine receptors and signaling (20 papers), Liver physiology and pathology (17 papers), Hepatitis C virus research (17 papers) and Hepatocellular Carcinoma Treatment and Prognosis (17 papers). The work is most often cited by research in Hepatology (2.0k citations), Cancer Research (2.7k citations), Immunology (3.0k citations), Oncology (2.9k citations) and Genetics (1.0k citations). Eithan Galun has collaborated with scholars based in Israel, United States and Germany. Frequent co-authors include Rinat Abramovitch, Eli Pikarsky, Ilan Stein, Rinnat M. Porat, Yinon Ben‐Neriah, Sharon Amit, Simcha Urieli-Shoval, Amnon Peled, Jonathan H. Axelrod and Abraham Hochberg. Their work appears in journals such as Molecular Therapy, Hepatology, PLoS ONE, Radiology and Oncotarget.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact